Local Institution - 0122 — Gig Harbor, Washington

Local Institution - 0122 is a clinical research site located in Gig Harbor, Washington, United States 98332.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 0122 has participated in 1 clinical trials.

Therapeutic areas: Bladder Cancer, Bladder Tumor, Muscle-Invasive Bladder Cancer.

Sponsors: Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Gig Harbor

Browse all research sites in Washington · View every site in Gig Harbor

• MultiCare Gig Harbor Medical Park
• Tacoma/Valley Radiation Oncology Centers-Gig Harbor
• GSK Investigational Site
• Personalized Lifestyle Medicine Center
• Northwest Medical Specialties, PLLC
• MultiCare Regional Cancer Center - Gig Harbor
• Research Site
• MultiCare Regional Cancer Center-Gig Harbor Medical Park
• Functional Medicine Research Center
• Northwest Medical Specialties
• Local Institution - 010-533 B
• Gig Harbor Medical Oncology

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0122?

Local Institution - 0122 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0122 conducted?

Local Institution - 0122 has 1 clinical trials on record. Their work covers Bladder Cancer, Bladder Tumor, Muscle-Invasive Bladder Cancer.

Is Local Institution - 0122 accredited by Crixeo Clinical Trials?

Local Institution - 0122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0122?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.